Is VolitionRX Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, VolitionRX Ltd (VNRX) is currently classified as NOT HALAL as of April 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is VolitionRX Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes VolitionRX Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of VolitionRX Ltd?

Muslim investors may consider investing in VolitionRX Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is VolitionRX Ltd classified as NOT HALAL?

Musaffa determines the Shariah status of VolitionRX Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for VolitionRX Ltd updated?

The Shariah compliance status of VolitionRX Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like VolitionRX Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of VolitionRX Ltd?

You can check the latest Shariah compliance status of VolitionRX Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

VNRX Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: April 03, 2026

Report Source: 2025 Annual Report

VolitionRX Ltd. Stock Analysis VNRX

United States Health Care Nano Cap Report: 2025 Annual

VolitionRX Ltd. engages in the development of blood-based cancer tests to help diagnose a range of cancers. The company is headquartered in Henderson, Nevada and currently employs 75 full-time employees. The company went IPO on 2015-02-06. The firm is dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, as well as disease and treatment monitoring. Through its subsidiaries, it is developing and commercializing blood tests to help diagnose and monitor a range of diseases, including cancers and diseases associated with NETosis, such as sepsis. Its key pillars are Nu.Q Vet, Nu.Q NETs, Nu.Q Discover, Nu.Q Cancer, and Capture-PCR. The Nu.Q Vet Cancer Test is commercially available as a cancer screening test in dogs. Nu.Q NETs is monitoring the immune system to save lives. Nu.Q Discover is a complete solution to profiling nucleosomes. Nu.Q Cancer monitoring disease progression, response to treatment and minimal residual disease. Capture-PCRTM is isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection.

Key Statistics of VolitionRX Ltd (VNRX)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$2.00$2.16

Today's Open

$2.00

Volume

174.44K

P/E Ratio (TTM)

52 Week Range

$2.00$18.80

Market Cap

18.84M

Avg. Volume

1.53M

Dividend Yield

Financial Metrics & Statements of VolitionRX Ltd (VNRX)

FAQ's for VolitionRX Ltd (VNRX)

According to Musaffa’s Shariah screening methodology, VolitionRX Ltd (VNRX) is currently classified as NOT HALAL as of April 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.